Anti-annexin V antibodies in neuro-Behçet patients: clinical significance and relation to disease activity.
Tamer A
TA
Gheita
Hatem
H
Samir
Hani
H
Hussein
D000328:Adult; D000367:Age Factors; D017304:Annexin A5 / Q000276:immunology*; D000888:Antibodies, Anti-Idiotypic / Q000097:blood*; D001528:Behcet Syndrome / Q000150:complications* / Q000188:drug therapy / Q000276:immunology*; D016022:Case-Control Studies; D003404:Creatinine / Q000097:blood; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D009422:Nervous System Diseases / Q000453:epidemiology / Q000209:etiology* / Q000276:immunology*; D012307:Risk Factors; D012720:Severity of Illness Index; D013256:Steroids / Q000627:therapeutic use
D017304:Annexin A5; D000888:Antibodies, Anti-Idiotypic; D013256:Steroids; D003404:Creatinine